Immucell (ICCC) Return on Capital Employed [ROCE] (2011 - 2026)
Immucell (ICCC) posted Return on Capital Employed [ROCE] of 6.14% for Q2 2026, up 1.77 percentage points from 4.37% a year earlier.
Powered by 
Analysis
Immucell (ICCC) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends
For FY2025, Immucell's Return on Capital Employed [ROCE] came in at 4.14%, up 8.24 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] shows a five-year change of +7.84 percentage points (FY2020 to FY2025).
- In prior years, Immucell's Return on Capital Employed [ROCE] was -4.10% in FY2024 (+10.23 pp), -14.32% in FY2023 (-8.79 pp), -5.53% in FY2022 (-6.17 pp) and 0.65% in FY2021 (+4.35 pp).
- The Q2 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q3 2016.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q2 2025, with a gain of 11.95 percentage points; the weakest was Q2 2023, with a drop of 15.60 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 16.76% |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 11.86% |
| 10 | Immucell | 94.82 Mn | 72.27 Mn | 2.44 Mn | 6.14% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.14% |
| Dec 31, 2025 | 4.11% |
| Sep 30, 2025 | 5.80% |
| Jun 30, 2025 | 4.37% |
| Mar 31, 2025 | -0.54% |
| Dec 31, 2024 | -4.06% |
| Sep 30, 2024 | -5.85% |
| Jun 30, 2024 | -7.58% |
| Mar 31, 2024 | -7.11% |
| Dec 31, 2023 | -11.87% |
| Sep 30, 2023 | -15.58% |
| Jun 30, 2023 | -14.76% |
| Mar 31, 2023 | -12.76% |
| Dec 31, 2022 | -5.40% |
| Sep 30, 2022 | -1.20% |
| Jun 30, 2022 | 0.84% |
| Mar 31, 2022 | 2.80% |
| Dec 31, 2021 | 0.62% |
| Sep 30, 2021 | -1.25% |
| Jun 30, 2021 | -2.64% |
API Access
Immucell Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ICCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();